S0664 Disease Control and Changes in Individual Treatment Outcomes From Week 14 to Week 52 With Vedolizumab or Adalimumab in Ulcerative Colitis: A VARSITY Trial Post Hoc Analysis
American Journal of Gastroenterology | October 24, 2020 | Volume: 115 | Issue: 1 | Pages: S332-S333
10.14309/01.ajg.0000704704.76894.ca